Closed 28 Aug 2017 Expression of Interest
Manufacturers Of Artemether-Lumefantrine (A-L) and Artesunate-Amodiaquine Cas-Aq) Tablets
About this tender
To support national and global efforts to increase access to affordable quality-assured products for malaria treatment, the Food and Drugs Authority (FDA), with technical assistance from the Promoting the Quality of Medicines (PQM) programme implemented by USP and with funding from the U.S. Agency for International Development, invites local pharmaceutical manufacturers to submit an Expression of Interest for inspection of their manufacturing sites to assess compliance with good manufacturing practices (GMP) for production of artemether-lumefantrine (A.-L) tablet.1; and artesunate-amodiaquine (AS-AQ) for the treatment of malaria.
The rest of this notice is for subscribers
- The full notice as issued, about 680 words
- Where and how to submit your bid
- Email and SMS alerts for new tenders like this one
One payment covers twelve months and every tender on the site.